Condition: Alcohol Use Disorder · Substance Use Disorders · Sponsor: Central Institute of Mental Health, Mannheim
The aim of this project is to investigate the potential of transcranial direct current stimulation (tDCS) to reduce cognitive deficits and substance craving in individuals with substance use disorders (SUD), with a focus on alcohol use disorder (AUD). Patients of any gender between the ages of 18 and 65 are examined who are in our inpatient and day clinic settings for a standard detoxification treatment program. As there are conflicting findings regarding the effective settings for tDCS as an adjunctive treatment in SUD (e.g., effects on inhibitory control seem to be sensitive to current direction), the aim is to examine and compare three different active tDCS conditions, a sham tDCS condition (placebo), inhibition training, and a control group of patients receiving only standard detoxification treatment. The aim is to identify the optimal electrode placement and current direction to positively influence both inhibitory control and craving, leading to improved treatment outcomes such as longer abstinence periods or reduced substance use after relapse.
This description comes directly from the study's public registry record.
Sabine Vollstädt-Klein, PhD · +4962117033912 · Sabine.Vollstaedt-Klein@zi-mannheim.de
Sarah Gerhardt, PhD · +4962117033927 · Sarah.Gerhardt@zi-mannheim.de
Always discuss trial participation with your own doctor first.
| Central Institute of Mental Health | Mannheim, Germany | Recruiting |
| Psychiatrisches Zentrum Nordbaden (Psychiatric Center Nordbaden) | Wiesloch, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06959342